Description
PT. Brightgene Biomedical Indonesia is a research-driven pharmaceutical company that aims to be at the forefront as a developer and producer of high-quality active pharmaceutical ingredients (API) for the healthcare needs of Indonesia and ASEAN markets. They focus on providing innovative solutions to meet the growing demands of the pharmaceutical industry by leveraging advanced research and development capabilities.
Services include:
– Development and production of active pharmaceutical ingredients
– Custom manufacturing services
– Quality control and assurance
– Regulatory support and consultancy
– Research and development collaboration
PT. Brightgene Biomedical Indonesia is dedicated to enhancing the pharmaceutical landscape with their comprehensive range of services and commitment to quality. For more information, please visit ptbrightgene.co.id.
Contact Information

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026

External Manufacturing Leaders West 2027
The biopharma external manufacturing leadership summit, June 2027











